Aimia (TSE:AIM - Get Free Report)'s stock had its "buy" rating reiterated by equities research analysts at TD Securities in a note issued to investors on Monday, Stock Target Advisor reports. They currently have a C$4.00 price objective on the stock. TD Securities' target price points to a potential upside of 50.94% from the stock's current price.
Aimia Price Performance
TSE:AIM traded up C$0.01 during mid-day trading on Monday, hitting C$2.65. 113,600 shares of the company's stock were exchanged, compared to its average volume of 31,866. The company has a market cap of C$254.87 million, a PE ratio of -3.26, a P/E/G ratio of -2.30 and a beta of 0.95. Aimia has a one year low of C$2.22 and a one year high of C$3.10. The business has a fifty day moving average price of C$2.43 and a 200 day moving average price of C$2.54.
About Aimia
(
Get Free Report)
Aimia Inc TSX: AIM is a holding company that makes long-term investments in private and public businesses through controlling or minority stakes. We target companies with durable economic advantages evidenced by a track record of substantial free cash flow generation over complete business cycles, strong growth prospects, and guided by strong, experienced management teams.
See Also
Before you consider Aimia, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aimia wasn't on the list.
While Aimia currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
